A randomized controlled comparison of flushing protocols in home care patients with peripherally inserted central catheters

Journal of Infusion Nursing

Volumn 37, Issue 4, 2014, Pages 270-281

  Lyons, Margaret G ^a,b   Phalen, Ann G ^c  

^a VILLANOVA UNIVERSITY   (United States)

^b Thomas Jefferson Home Infusion Service   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; AMPICILLIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; DAPTOMYCIN; ERTAPENEM; GENTAMICIN; HEPARIN; NAFCILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; ROCEPHI; UNCLASSIFIED DRUG; VANCOMYCIN; VANCOSIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CATHETER CARE; CATHETER OCCLUSION; CONTROLLED STUDY; DRUG USE; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CATHETERIZATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; LAVAGE; MIDDLE AGED; SINGLE BLIND PROCEDURE; YOUNG ADULT;

ADULT; AGED; CATHETERIZATION, PERIPHERAL; CLINICAL PROTOCOLS; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; THERAPEUTIC IRRIGATION; YOUNG ADULT;

EID: 84903947343     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0000000000000050     Document Type: Article

References (42)

1. Patient Protection and Affordable Care Act.42 USC §2702 ( 2010 ).
2. National Prevention, Health Promotion and Public Health Council. National prevention strategy: America's plan for better health and wellness.http://www. healthcare.gov/prevention/nphpphc/index.html.Published June 2011. Accessed October 23, 2011.
3. Chopra V , O'Horo JC , Rogers MA , Maki DG , Safdar N.The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.Infect Control and Hosp Epidemiol.2013 ; 34 ( 9 ): 908-918 .
4. Moureau N , Poole S , Murdoch MA , Gray S , Semba CP.Central venous catheters in home infusion care: outcomes analysis in 50,470 patients.J Vasc Intervent Radiol.2002 ; 13 : 1009-1016 .
5. Gorski L , Czaplewski LM.Peripherally inserted central catheters and midline catheters for the home care nurse.J Infus Nurs.2004 ; 27 ( 6 ): 399-409 .
6. Hadaway L.Technology of flushing vascular access devices.J Infus Nurs.2006 ; 29 ( 3 ): 137-145 .
7. Goode C , Titler M , Rakel B , et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications.Nurs Res.1991 ; 40 ( 8 ): 324-330 .
8. LeDuc K.Efficacy of normal saline solution versus heparin solution for maintaining patency of intravenous catheters in children.J Emerg Nurs.1997 ; 23 : 306-309 .
9. Peterson FY , Kirchoff KT.Analysis of the research about heparinized verses nonheparinized intravascular lines.Heart Lung.1991 ; 20 : 631-642.
10. Randolph A , Cook D , Gonzales C , Andrew M.Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.Br Med J.1998 ; 316 : 969-975 .
11. US Food and Drug Administration.Public health update: recall of heparin sodium for injection.http://www.fda.gov/drugs/drugsafety/ postmarketdrugsafetyinformationforpatientsandproviders/ucm112665.htm.Published February 28, 2008. Accessed September 30, 2011.
12. Cooney MF.Heparin-induced thrombocytopenia: advances in diagnosis and treatment.Crit Care Nurs.2006 ; 26 : 30-36 .
13. Jonker M , Osterby K , Vermeulen LC , Kleppin S , Kudsk K.Does low-dose heparin maintain central venous access device patency? A comparison of heparin versus saline during a period of heparin shortage.J Parenter Enteral Nutr.2010 ; 34 ( 4 ): 444-449 .
14. Cathflo Activase (alteplase) [package insert].South San Francisco, CA : Genentech, Inc ; 2001.http://www.fda.gov/downloads/Drugs/./ucm088609.pdf. Accessed September 30, 2011.
15. Bowers L , Speroni K , Jones L , Atherton M.Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure luer-activated devices.J Infus Nurs.2008 ; 31 ( 1 ): 22-27 .
16. Alexander M , Corrigan A , Gorski L , Hankins J , Perucca R , eds. Infusion Nursing: An Evidence-Based Approach.3rd ed. St Louis, MO : Saunders/Elsevier ; 2010 : 499-500 .
17. Infusion Nurses Society.Infusion nursing standards of practice.J Infus Nurs.2011 ; 34 ( 1 suppl ): S1-110 .
18. Cancer Care Ontario.Central Venous Access Device Guideline Panel. Managing central venous access devices in cancer patients: a clinical practice guideline.http://www.cancercare.on.ca/toolbox/qualityguidelines/clin-program/ nursing-ebs.Published September 25, 2006. Accessed February 22, 2010.
19. Oncology Nursing Society.Access Device Guidelines: Recommendations for Nursing Practice and Education.3rd ed. Pittsburgh, PA : Oncology Nursing Society ; 2011 .
20. Timoney JP , Malkin MG , Leone DM , et al. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices.J Clin Oncol.2002 ; 20 ( 7 ): 1918-1922 .
21. Locke CF , Dooley J , Gerber J.Rates of clinically apparent heparin- induced thrombocytopenia for unfractionated heparin vs low molecular weight heparin in nonsurgical patients are low and similar.Thromb J.2005 ; 3 ( 4 ): 1-5 .
22. Hirsh J , Anand SS , Halperin JL , Fuster V.Mechanism of action and pharmacology of unfractionated heparin.Thromb Vasc Biol.2001 ; 21 : 1094-1096.http://atvb.ahajournals.org/content/21/7/1094.full.Accessed January 13, 2012.
23. Baskin J , Pui C , Reiss U , et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.Lancet.2009 ; 374 : 159-169 .
24. Bishop L , Dougherty L , Bodenham A , et al. Guidelines on the insertion and management of central venous access devices in adults.Inter J Labor Hematol.2007 ; 29 : 261-278 .
25. Edwards JR , Peterson KD , Mu YP , et al. National healthcare safety network (NHSN) report: data summary for 2006-2008.Am J Infect Control.2009 ; 37 : 783-805 .
26. Institute for Healthcare Improvement.Implement the central line bundle.http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ ImplementtheCentralLineBundle.htm. Accessed January 25, 2010.
27. Marschall JM , Mermel LA , Classen DM , et al. Strategies to prevent central line-associated bloodstream infection in acute care hospitals.Infect Control Hosp Epidemiol.2008 ; 29 :S22-S30 .
28. Massachusetts Department of Health.Prevention of bloodstream infections.In: Prevention and Control of Healthcare-Associated Infections in Massachusetts. Part 1 Final Recommendation of the Expert Panel.Boston, MA : Betsy Lehman Center for Patient Safety and Medical Reduction/JSI Research and Training Institute ; 2008 .
29. Mermel LA , Allon M , Bouza E , et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America.Clin Inf Dis.2009 ; 49 : 1-45 .
30. Muto CJ , Jernigan JA , Ostrowsky BE , et al. SHEA.SHEA guideline for preventing nosocomial transmission of multidrugresistant strains of staphylococcus aureus and enterococcus.Infect Control Hosp Epidemiol.2003 ; 24 : 362-386 .
31. O'Grady NP , Alexander M , Burns LA , et al. Guidelines for the prevention of intravascular catheter-related infections.Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) Publications.http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html. Published 2011. Accessed December 19, 2011.
32. Pratt R , Pellowe C , Wilson J , et al. Epic 2: national evidence-based guidelines for preventing hospital-associated infections in NHS hospitals in England.J Hosp Infect.2007 ; 65 ( suppl 1) : S1-S31 .
33. Pham K.Statement on heparin safety and shortages.http://www.ppag.org/ heparin.Accessed January 25, 2010.
34. Nachman R , Silverstein R.Hypercoagulable states.Ann Intern Med.1993 ; 119 : 819-827 .
35. Doig GS , Simpson F.Randomization and allocation concealment: a practical guide for researchers.J Crit Care.2005 ; 20 ( 2 ): 191-193 .
36. ICU Medical.MicroCLAVE DFU Literature.http://www.icumed.com/products/ infusion-therapy/needlefree-vascular-accessdevices/microclave.aspx.Accessed October 6, 2011.
37. Mehall JR , Saltzman DA , Jackson RJ , Smith SD.Fibrin sheath enhances central venous catheter infection.Crit Care Med.2002 ; 30 : 908-912 .
38. Furie BF , Furie BC.Mechanisms of thrombus formation.N Engl J Med.2008 ; 359 : 938-949 .
39. Chandra J , Mukherjee PK , Ghannoum MA.Candida biofilms associated with CVC and medical devices.Mycoses.2012 ; 55 ( suppl 1) : 46-57 .
40. Deh Carvalho Machado J , Marques Suez VM , de Castro Figueiredo JF , Marchino JS.Biofilms, infection and parenteral nutrition therapy.J Parenter Enteral Nutr.2009 ; 33 ( 4 ): 397-403 .
41. Retzinger GS , Chandler LJ , Cook BC.Complexation with heparin prevents adhesion between fibrin-coated surfaces.J Biol Chem.1992 ; 267 ( 34 ): 24356-24362 .
42. Schilling S , Doellman D , Hutchinson N , Jacobs B.The impact of needless connector device design on central venous catheter occlusion in children: a prospective, controlled trial.J Parenter Enteral Nutr.2006 ; 30 ( 2 ): 85-90 .